Company Description

An AI-enabled drug discovery engine for GPCRs (G-Protein Coupled Receptors) that not only helps with target enablement, but also with ADME (absorption, distribution, metabolism, excretion) at the hit stage (earlier than normal) to help optimize clinical prediction. Superluminal Medicines is a generative biological and chemical company accelerating new possibilities in drug discovery and development.